Literature DB >> 5557519

Ocular and nervous system involvement in angioma serpiginosum.

P C Gautier-Smith, M D Sanders, K V Sanderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5557519      PMCID: PMC1208415          DOI: 10.1136/bjo.55.7.433

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  Symposium: The Sturge-Weber Syndrome.

Authors:  G Morgan
Journal:  Proc R Soc Med       Date:  1963-05

2.  Incipient lesions of von Hippel-Lindau disease.

Authors:  D O Jesberg; W H Spencer; W F Hoyt
Journal:  Arch Ophthalmol       Date:  1968-11

3.  Angioma serpiginosum, a comparative study.

Authors:  L P Barker; P M Sachs
Journal:  Arch Dermatol       Date:  1965-12

4.  Retinal telangiectasia associated with hypogammaglobulinemia.

Authors:  M Frenkel; H P Russe
Journal:  Am J Ophthalmol       Date:  1967-02       Impact factor: 5.258

  4 in total
  6 in total

Review 1.  Cavernous haemangioma of the retina and optic disc. A report of three cases and a review of the literature.

Authors:  R A Lewis; M H Cohen; G N Wise
Journal:  Br J Ophthalmol       Date:  1975-08       Impact factor: 4.638

2.  Angioma serpiginosum: a simulator of purpura.

Authors:  N H Cox; W D Paterson
Journal:  Postgrad Med J       Date:  1991-12       Impact factor: 2.401

3.  Atypical angioma serpiginosum.

Authors:  Ju-Hsin Chen; Kuo-Hsien Wang; Chung-Hong Hu; Jainn-Shiun Chiu
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

4.  Tumors of the optic nerve.

Authors:  H Eggers; F A Jakobiec; I S Jones
Journal:  Doc Ophthalmol       Date:  1976-04-28       Impact factor: 2.379

5.  [Angiomatosis retinae (et papillae)].

Authors:  H Pau
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-05-07

6.  Classification and management of hereditary retinal angiomas.

Authors:  J J Augsburger; J A Shields; R E Goldberg
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.